arrow
N

Nyanda Elias Ntinginya

University of California Los Angeles
H指数:25
被引数:3,206

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Point-of-care early infant HIV diagnosis at birth in a pragmatic cluster-randomized trial in Mozambique and Tanzania: A comparative cost and cost-effectiveness study

在莫桑比克和坦桑尼亚进行的实用性集群随机试验中,出生时进行早期婴儿HIV诊断的床旁检测:一项比较成本和成本效益的研究

2026-05-010
OA
Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis

世卫组织结核病治疗决策算法对推定结核病儿童的诊断准确性: 个体参与者数据荟萃分析

2025-11-010
PRE
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy

HIV-1精英中和者队列的表征分析揭示了一种靶向CD4bs的广谱中和抗体,可用于HIV-1的预防和治疗

2025-10-060
OA
Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings

QIAreach QuantiFERON-TB侧向流动纳米颗粒荧光检测法在三个高负担地区结核病家庭接触者中的结核感染诊断评估

2025-09-190
OA
Facilitators and barriers to implementation of HPV vaccination in Tanzania: a mixed-methods study exploring perspectives from national, subnational, and community stakeholders, 2018–2023

影响坦桑尼亚HPV疫苗接种实施的因素与障碍:一项探讨国家、次国家和社区利益相关者视角的混合方法研究,2018–2023

Vaccine
IF3.5
2025-08-010
OA
Impact of point-of-care maternal viral load testing at delivery on vertical HIV transmission risk assessment and neonatal prophylaxis: a cluster randomized trial

产时床旁母体病毒载量检测对垂直HIV传播风险评估和新生儿预防的影响:一项群组随机试验

2025-07-280
OAAI
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial

Sutezolid与bedaquiline、delamanid和moxifloxacin联合治疗肺结核(PanACEA-SUDOCU-01):一项前瞻性、开放标签、随机、Ⅱb期剂量探索试验

2025-07-080
OAAI
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial

德尔帕索利德联合贝达喹啉、德拉马尼和莫西沙星治疗肺结核(PanACEA-DECODE-01):一项前瞻性、随机、开放标签、IIb期剂量探索试验

2025-07-080
OAAI
Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries

微生物学确诊肺结核患者家庭接触者中结核感染相关危险因素:来自3个高结核负担国家的数据

2025-07-012
OAAI
Effectiveness of a clinical decision support algorithm (ePOCT plus ) in improving quality of care for sick children in primary health facilities in Tanzania (DYNAMIC project): results from a cluster randomized trial

坦桑尼亚基层卫生设施中ePOCT plus临床决策支持算法在改善患病儿童护理质量方面的有效性(DYNAMIC项目):一项集群随机试验的结果

2025-03-010
OAAI
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis

N-乙酰半胱氨酸调节结核病中氧化、炎症和感染的标志物

2025-02-011
OAAI
Impact of Point-of-Care Birth Test-and-Treat on Clinical Outcomes Among Infants With Human Immunodeficiency Virus: A Cluster-Randomized Trial in Mozambique and Tanzania
2024-11-080
OAAI
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)
2024-08-151
OAAI
Detection of Bombali Virus in a Mops condylurus Bat in Kyela, Tanzania
2024-07-310
OAAI
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without Human Immunodeficiency Virus in Africa

在非洲有和没有人类免疫缺陷病毒的成年人中加速异源2剂量埃博拉疫苗方案的安全性和免疫原性

2024-04-241
PRE